Asked by: Lord Doyle (Non-affiliated - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what assessment they have made of the draft guidance from NICE which states that it cannot recommend the use of lenacapavir for reducing the risk of HIV; and what impact this will have on their target to end new HIV transmissions in England by 2030.
Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)
No assessment has been made. The National Institute for Health and Care Excellence (NICE) develops its guidance independently based on the evidence of clinical and cost effectiveness. NICE has not yet published final guidance on lenacapavir and is currently consulting on its draft guidance.
Asked by: Lord Doyle (Non-affiliated - Life peer)
Question to the HM Treasury:
To ask His Majesty's Government whether they plan to participate in international negotiations on the establishment of a Defence, Security and Resilience Bank, following the Canadian government’s announcement on 30 January of its intention to explore this with European and NATO partners.
Answered by Lord Livermore
Challenging times for global and European security call for creative solutions. The UK is therefore stepping up work with likeminded allies on the most effective option for a collective approach to defence spending and procurement.
Together, we can accelerate vital investment and maximise the potential of historic spending uplifts to meet the scale of our shared defence and security commitments.